Secreted protein, acidic and rich in cysteine-like 1 (SPARCL1) is down regulated in aggressive prostate cancers and is prognostic for poor clinical outcome.
about
Employing an orthotopic model to study the role of epithelial-mesenchymal transition in bladder cancer metastasisInvestigation of miR-21, miR-141, and miR-221 expression levels in prostate adenocarcinoma for associated risk of recurrence after radical prostatectomy.Epigenetic clustering of lung adenocarcinomas based on DNA methylation profiles in adjacent lung tissue: Its correlation with smoking history and chronic obstructive pulmonary diseaseThe metastasis suppressor NME1 regulates expression of genes linked to metastasis and patient outcome in melanoma and breast carcinoma.Molecular portraits revealing the heterogeneity of breast tumor subtypes defined using immunohistochemistry markers.Androgen-Regulated SPARCL1 in the Tumor Microenvironment Inhibits Metastatic Progression.Germline Variants in Asporin Vary by Race, Modulate the Tumor Microenvironment, and Are Differentially Associated with Metastatic Prostate CancerPersonalized management in low-risk prostate cancer: the role of biomarkers.E2f3 in tumor macrophages promotes lung metastasis.Type 1 diabetes cadaveric human pancreata exhibit a unique exocrine tissue proteomic profileSPARCL1 suppresses metastasis in prostate cancer.Matricellular protein SPARCL1 regulates tumor microenvironment-dependent endothelial cell heterogeneity in colorectal carcinoma.SPARCL1 is a novel predictor of tumor recurrence and survival in hilar cholangiocarcinoma.HES6 promotes prostate cancer aggressiveness independently of Notch signalling.Large-scale RNA-Seq Transcriptome Analysis of 4043 Cancers and 548 Normal Tissue Controls across 12 TCGA Cancer Types.Practical detection of a definitive biomarker panel for Alzheimer's disease; comparisons between matched plasma and cerebrospinal fluids-SHIP expression identifies a subset of murine basal prostate cells as neonatal stem cellsAssociations of tumor suppressor SPARCL1 with cancer progression and prognosisgp78 is specifically expressed in human prostate cancer rather than normal prostate tissue.Integrated analysis reveals down-regulation of SPARCL1 is correlated with cervical cancer development and progression.A Novel S100A8/A9 Induced Fingerprint of Mesenchymal Stem Cells associated with Enhanced Wound Healing.Secreted protein acidic and rich in cysteine-like 1 suppresses metastasis in gastric stromal tumors.SPARCL1 suppresses the proliferation and migration of human ovarian cancer cells via the MEK/ERK signaling
P2860
Q33798322-59835ABE-C804-4DD3-84E5-5B1121606A6CQ34381845-42373A4F-BEE6-4A49-B715-AE6F7539856AQ34629271-40679B30-E8FF-45C9-8B06-6C4E6C0BC1DDQ35536511-6848D571-EC2A-4D66-9389-11CF61B70CD2Q36099968-B20E8A12-0B56-414E-AFBD-2C05747898A6Q36172537-7A728C17-9AF2-4821-A2EB-B275036AA69FQ36471474-2589C788-8081-4D26-A035-48EC953A67D4Q36495701-4BC15283-0408-4B94-B6A5-56554C6AF3ADQ36885525-E58BE1CA-2725-4C27-AEED-72E0459DFCF9Q36970856-BB98AF6F-FFCE-49D4-B49A-7ABBC9AC05EDQ37337322-15300C13-EA47-475B-9810-D8375D9FCC5CQ37395835-D8FC179C-FE06-4AB4-BAB8-EC42226D88C8Q38826019-7E647C8F-B152-48DD-895E-0C6F3FA4CE57Q38888488-D9AF525D-7E48-4D96-8A44-0E385FF6ECA1Q40622697-A0E26AD8-E5F5-4F40-84A1-B24EDB21EDC9Q40950201-2B461840-165F-4A13-9049-694F764052D8Q41260235-9F6E8D45-AE4C-47E9-9374-786B43CC22F2Q41613171-E15DDD62-8B7C-4AAB-B35C-CB761C91DFE1Q42438354-36F37675-278C-4DFE-A696-2E41ADD555DFQ47657967-0D2FE23E-4635-4AFC-BDCC-C13ED58DA673Q52579512-88DC8A90-D549-410A-89E0-30C3CADC89F8Q55518600-9D2F0F34-1742-40A1-91EA-7E99CC46A36BQ58796673-4B01E065-E572-46A5-A48D-B1385723A1DE
P2860
Secreted protein, acidic and rich in cysteine-like 1 (SPARCL1) is down regulated in aggressive prostate cancers and is prognostic for poor clinical outcome.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Secreted protein, acidic and r ...... tic for poor clinical outcome.
@ast
Secreted protein, acidic and r ...... tic for poor clinical outcome.
@en
type
label
Secreted protein, acidic and r ...... tic for poor clinical outcome.
@ast
Secreted protein, acidic and r ...... tic for poor clinical outcome.
@en
prefLabel
Secreted protein, acidic and r ...... tic for poor clinical outcome.
@ast
Secreted protein, acidic and r ...... tic for poor clinical outcome.
@en
P2093
P2860
P50
P356
P1476
Secreted protein, acidic and r ...... tic for poor clinical outcome.
@en
P2093
Ben Ho Park
Bora Gurel
Elizabeth A Platz
Ismael A Vergara
Mercedeh Ghadessi
Paula J Hurley
Rebecca M Miller
Robert B Jenkins
Sarah B Peskoe
Zhenhua Huang
P2860
P304
14977-14982
P356
10.1073/PNAS.1203525109
P407
P50
P577
2012-08-27T00:00:00Z